Form 4: Celanese Director Acquires Phantom Stock as Dividends

Celanese Director Jay V. Ihlenfeld acquired 7.84 shares of phantom stock as dividend equivalents on deferred compensation, increasing his beneficial ownership to 10,235.059 shares.

Summary

• Jay V. Ihlenfeld, a Director of Celanese Corp (CE), acquired 7.84 shares of phantom stock.
• The transaction occurred on November 12, 2025.
• The phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan.
• Each share of phantom stock represents the right to receive one share of Celanese Common Stock.
• The phantom stock becomes payable in shares of Common Stock following the termination of Mr. Ihlenfeld's service as a director.
• The price of the derivative security (phantom stock) was $39.12 per share.
• Following this transaction, Mr. Ihlenfeld beneficially owns 10,235.059 shares of phantom stock.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as it indicates a director's beneficial ownership is increasing, aligning their interests with shareholders, even if it's a routine compensation-related transaction.

Positives

• The acquisition of phantom stock as dividend equivalents increases the director's beneficial ownership, aligning their interests further with shareholders.
• The transaction is part of a pre-existing deferred compensation plan, indicating a structured approach to executive compensation and retention.

Negatives

• None mentioned in this filing.

Risks

• None mentioned in this filing.

Future Outlook

The phantom stock acquired will become payable in shares of Common Stock following the termination of the reporting person's service as a director of the Company, as provided in the 2008 Deferred Compensation Plan.

Industry Context

This filing is a routine insider transaction report and does not provide broader industry context. It reflects standard compensation practices for directors within publicly traded companies, where deferred compensation plans often include dividend equivalents to maintain the value of deferred equity holdings.

Comparison to Industry Standards

• The use of phantom stock as a component of director compensation, particularly for dividend equivalents on deferred compensation, is a common practice in many large public companies across various industries. This mechanism helps align director interests with long-term shareholder value without immediate equity issuance.
• Companies like Dow Inc. (DOW) and DuPont de Nemours, Inc. (DD), which operate in similar chemical and materials sectors, often utilize comparable deferred compensation plans for their executives and directors, including provisions for dividend equivalents on deferred stock units.

Stakeholder Impact

• Shareholders: Minor positive signal due to increased director alignment with company performance through beneficial ownership.

Next Steps

• The phantom stock will convert into shares of Common Stock upon the termination of Jay V. Ihlenfeld's service as a director of Celanese Corp.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary acquisition of phantom stock as dividend equivalents under a deferred compensation plan. Such a transaction, while increasing a director's beneficial ownership, is not typically indicative of new strategic developments or significant changes in company fundamentals that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate, maintaining existing positions based on broader company performance and market conditions rather than this specific insider filing.

Keywords

Celanese, CE, Form 4, Insider Transaction, Phantom Stock, Deferred Compensation, Director, Dividend Equivalents